Zhiqiang Xie

机构：Fujian Medical University, Henan Provincial Center for Disease Control and Prevention, Union Hospital · ORCID：0000-0002-7833-5308

发表论文 104 篇 · 总被引 3835 次 · h-index 16

代表论文

• Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response (2024 · Journal of Controlled Release · 被引 18)
• Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study (2024 · Vaccines · 被引 7)
• Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months (2023 · International Journal of Infectious Diseases · 被引 7)
• A trinity strategy: Mesoporous platinum nanoparticles serve as a photoenhanced nanoplatform for tumor immunotherapy (2024 · Chemical Engineering Journal · 被引 6)
• Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study (2023 · Human Vaccines & Immunotherapeutics · 被引 6)
• Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trial (2023 · Human Vaccines & Immunotherapeutics · 被引 4)